Oral diazoxide versus placebo for severe or recurrent neonatal hypoglycaemia: Neonatal Glucose Care Optimisation (NeoGluCO) study – a randomised controlled trial

INTRODUCTION: Infants with severe or recurrent transitional hypoglycaemia continue to have high rates of adverse neurological outcomes and new treatment approaches are needed that target the underlying pathophysiology. Diazoxide is one such treatment that acts on the pancreatic β-cell in a dose-depe...

Descripción completa

Detalles Bibliográficos
Autores principales: Laing, Don, Walsh, Eamon, Alsweiler, Jane M, Hanning, Sara M, Meyer, Michael P, Ardern, Julena, Cutfield, Wayne S, Rogers, Jenny, Gamble, Greg D, Chase, J Geoffrey, Harding, Jane E, McKinlay, Christopher JD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389093/
https://www.ncbi.nlm.nih.gov/pubmed/35977769
http://dx.doi.org/10.1136/bmjopen-2021-059452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389093/
https://www.ncbi.nlm.nih.gov/pubmed/35977769
http://dx.doi.org/10.1136/bmjopen-2021-059452

Ejemplares similares